PERSPECTA

News from every angle

Back to headlines

Bristol-Myers Squibb (BMY) Announces Positive Data from the Phase 3 SCOUT-HCM Trial of Camzyos

2 Apr, 14:46 — 2 Apr, 14:46
PostShare

Sources

Showing 1 of 1 sources